Therapeutic and diagnostic aspects of the new coronavirus infection COVID-19 in obstetric practice


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The purpose of this review is to summarize the global experience in the diagnosis and treatment of the new coronavirus infection COVID-19 in obstetric patients, which can be applied in the practical work of antenatal clinics and maternity hospitals in a pandemic. The current COVID-19 pneumonia pandemic is a serious public health problem, especially for vulnerable populations. Pregnant women and newborns represent a high risk group during outbreaks of infectious diseases. To date, the literature describes the perinatal outcomes of385 pregnant women infected with COVID-19, with no clinical evidence of vertical transmission. The review analyzes published data on the Wuhan coronavirus infectious potential to cause the maternal, fetal and newborn morbidity, and other adverse obstetric outcomes. The controversial issues of the etiotropic treatment of CoV-pneumonia and the existing diagnostic problems are discussed. Particular attention is paid to ensuring safety in obstetric institutions. At present, the most urgent issues include the search for antiviral drugs with the most proven efficacy and safety for the pregnant woman and the fetus, and the validation of vaccines being created.

Толық мәтін

Рұқсат жабық

Авторлар туралы

E. Kakhiani

North-Western State Medical University n.a. I.I. Mechnikov

St. Petersburg, Russia

N. Korobkov

North-Western State Medical University n.a. I.I. Mechnikov

Email: nikolai_korobkov@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Obstetrics and Gynecology n.a. S.N. Davydov 41, Kirochnaya str., St. Petersburg 191015, Russian Federation

V. Vasiliev

North-Western State Medical University n.a. I.I. Mechnikov; Scientific Research Institute of Children's Infections

St. Petersburg, Russia

E. Romanova

North-Western State Medical University n.a. I.I. Mechnikov

St. Petersburg, Russia

Әдебиет тізімі

  1. Liu H., Wang L.L., Zhao S.J., et al. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139:103122. Doi: 10.1016/j. jri.2020.103122.
  2. Dashraath P, Wong J.L.J., Lim M.X.K., et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy Am J Obstet Gynecol. 2020;222(6):521-31. Doi: 10.1016/j. ajog.2020.03.021.
  3. Zhao Y, Zhao Z., Wang Y, et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. 2020.01.26.919985. doi: 10.1101/2020.01.26.919985.
  4. Sevajol M, Subissi L., Decroly E., et al. Review Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus. Virus Res. 2014;194:90-9. Doi: 10.1016/j. virusres.2014.10.008.
  5. Di Mascio D., Khalil A., Saccone G., et al. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. Doi: 10.1016/j. ajogmf.2020.100107.
  6. Schwartz D.A., Graham A.L. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12(2):194. doi: 10.3390/v12020194.
  7. Временные методические рекомендации Минздрава России «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). М., 2020. Версия 7 (03.06.2020)».
  8. Antoun L., Taweel N.E., Ahmed I., et al. Maternal COVID-19 infection, clinical characteristics, pregnancy, and neonatal outcome: A prospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2020:S0301-2115(20)30448-6. doi: 10.1016/j.ejogrb.2020.07.008.
  9. Panahi L., Amiri M., Pouy S. Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review. Arch Acad Emerg Med. 2020;8(1):e34. PMC7092922.
  10. Методические рекомендации. Организация оказания медицинской помощи беременным, роженицам, родильницами новорожденным при новой коронавирусной инфекции COVID-19. Москва: Министерство здравоохранения РФ, май 2020. 52 с.
  11. Brann D.H., Tsukahara T., Weinreb C., et al. Nonneuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. SciAdv. 2020;31(6):eabc5801. doi: 10.1126/sciadv. abc5801.
  12. Wong S.F, Chow K.M., de Swiet M. Severe acute respiratory syndrome and pregnancy. BJOG. 2003;110(7):641-42. doi: 10.1046/j.1471-0528.2003.03008.x.
  13. Capobianco G., Saderi L., Aliberti S., et al. COVID-19 in pregnant women: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;16:S0301-2115(20)30446-2. doi: 10.1016/j.ejogrb.2020.07.006.
  14. Zhou P, Zhou P, Yang X.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-73. Doi: 10.1038/ s41586-020-2012-7.
  15. Rasmussen S.A., Smulian J.C., Lednicky J.A., et al. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020;222(5):415-26. doi: 10.1016/j.ajog.2020.02.017.
  16. Coronavirus (Covid-19). URL: https:// coronavirusmonitor.ru.
  17. Lai C.C., Liu Y.H., Wang C.Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020;53(3):404-12. Doi: 10.1016/j. jmii.2020.02.012.
  18. Pan Y., Zhang D., Yang P, et al. Viral load of SARS-CoV-2 in clinical samples. Lancet. Infect Dis. 2020;20(4):411-2. doi: 10.1016/S1473-3099(20)30113-4.
  19. Motley M.P, Bennett-Guerrero E., Fries B.C., et al. Review of Viral Testing (Polymerase Chain Reaction) and Antibody/Serology Testing for Severe Acute Respiratory Syndrome-Coronavirus-2 for the Intensivist. Crit Care Explor. 2020;2(6):e0154. doi: 10.1097/CCE.0000000000000154.
  20. Всемирная организация здравоохранения. Клиническое руководство по ведению пациентов с тяжелой острой респираторной инфекцией при подозрении на инфицирование новым коронавирусом (2019-nCoV). Временные рекомендации.
  21. World Health Organization Coronavirus disease 2019 (COVID-19) situation report - 44. URL: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019.
  22. Jain C. ACOG committee opinion no. 723: guidelines for diagnostic imaging during pregnancy and lactation. Obstetr Gynecol. 2019;133(1):186.
  23. Rochwerg B., Granton D., Wang D.X., et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intens Care Med. 2019;45:563-72. doi: 10.1007/s00134-019-05590-5.
  24. Li Y, Zhao R., Zheng S. Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China. Emerg Infect Dis. 2020;26(6):1335-36. doi: 10.3201/eid2606.200287.
  25. Zhu H., Zhu H., Wang L., et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51-60. doi: 10.21037/tp.2020.02.06.
  26. Zhang L., Zhang L., Jiang Y. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province. Zhonghua fu Chan ke za zhi. 2020;55(3):166-71. Doi: 10.3760/ cma.j.cn112141-20200218-00111.
  27. Chen S., Chen S., Huang B. Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases. Zhonghua Bing li xue za zhi. Chin J Pathol. 2020;49(5):418-23. Doi: 10.3760/ cma.j.cn112151-20200225-00138.
  28. Chen Y, Peng H., Wang L. Infants born to mothers with a new coronavirus (COVID-19). Front Pediatr. 2020;8:104. doi: 10.3389/fped. 2020.00104.
  29. Chen H., Guo J.M.S., Chen W. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-15. Doi: 10.1016/ S0140-6736(20)30360-3.
  30. Ong S.W.X., Tan Y.K., Chia PY., et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323(16):1610-12. doi: 10.1001/jama.2020.3227.
  31. Серов В.Н., Адамян Л.В., Филиппов О.С. и др. Кесарево сечение, показания, методы обезболивания, хирургическая техника, антибиотикопрофилактика, ведение послеоперационного периода. Проблемы репродукции. 2018;24(S6):27-55. [
  32. Chen R., Zhang Y, Huang L. et al. Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients. Can J Anesth. 2020;67:655-63. doi: 10.1007/s12630-020-01630-7.
  33. Cao Q, Chen Y.C., Chen C.L., et al. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J Formos Med Assoc. 2020;119(3):670-73. Doi: 10.1016/j. jfma.2020.02.009.
  34. Yuen K.-S, Ye Z.-W., Fung S.-Y, et al. SARSCoV-2 and COVID-19: The Most Important Research Questions. Cell Biosci. 2020;10(1):1-5. doi: 10.1186/s13578020-00404-4.
  35. de Wit E., Feldmann F, Cronin J. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci. 2020;117(12):6771-76. doi: 10.1073/pnas.1922083117.
  36. Wang M., Cao R., Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71. doi: 10.1038/s41422-020-0282-0.
  37. Lin L., Lu L., Cao W., et al. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-A Review of immune changes in patients with viral pneumonia. Emerg Microb Infect. 2020;9(1):727-32. doi: 10.1080/22221751.2020.1746199.
  38. Hulme K.D., Gallo L.A., Short K.R. Influenza virus and glycemic variability in diabetes: a killer combination? Front Microbiol. 2017;8:861. doi: 10.3389/fmicb.2017.00861.
  39. Gustavson K., Ask H., Ystrom E. Maternal fever during pregnancy and off spring attention deficit hyperactivity disorder. Sci Rep. 2019;9(1):1-10. doi: 10.1038/s41598-019-45920-7.
  40. Sass L., Urhoj S.K., Kj&rgaard J. Fever in pregnancy and the risk of congenital malformations: a cohort study. BMC. Pregnancy Childbirth. 2017;17(1):413. Doi: 10.1186/ s12884-017-1585-0.
  41. Smith-Bindman R., Lipson J., Marcus R. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169(22):2078-86. Doi: 10.1001/ archinternmed.2009.427.
  42. Guan W., Ni Z., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382(18):1708-20. Doi: 10.1056/ NEJMoa2002032.
  43. Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72-3. doi: 10.5582/bst.2020.01047.
  44. Karunajeewa H.A., Salman S., Mueller I. Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy Antimicrob Agents Chemother. 2010;54(3):1186-92. doi: 10.1128/AAC.01269-09.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2020

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>